Trial intelligence / Profile preview

Lexapro for Major Depression in Temporal Lobe Epilepsy

NCT00595699Phase 4Completed

Sponsor
Erich J. Conrad, M.D.
Start
Nov 2006
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Erich J. Conrad, M.D.. Started Nov 2006; status: completed.

02

Drugs

escitalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00595699.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00595699.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call